FORTE BIOSCIENCES INC's ticker is FBRX and the CUSIP is 34962G109. A total of 35 filers reported holding FORTE BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $946,034 | -22.9% | 1,761,702 | 0.0% | 0.68% | -16.6% |
| Q1 2024 | $1,226,497 | -15.3% | 1,761,702 | 0.0% | 0.81% | -26.2% |
| Q4 2023 | $1,447,591 | +24.1% | 1,761,702 | 0.0% | 1.10% | +2.3% |
| Q3 2023 | $1,166,247 | -35.4% | 1,761,702 | +1.5% | 1.07% | -34.0% |
| Q2 2023 | $1,804,478 | +3.0% | 1,735,075 | 0.0% | 1.62% | +7.1% |
| Q1 2023 | $1,752,426 | +19.9% | 1,735,075 | +18.7% | 1.52% | +8.5% |
| Q4 2022 | $1,461,364 | – | 1,461,364 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 79,823 | $3,872,000 | 2.49% |
| BVF INC/IL | 777,553 | $37,719,000 | 2.05% |
| ArrowMark Colorado Holdings LLC | 2,936,708 | $142,460,000 | 1.36% |
| MYDA Advisors LLC | 34,000 | $1,649,000 | 0.86% |
| EAM Global Investors LLC | 31,015 | $1,505,000 | 0.55% |
| EAM Investors, LLC | 21,723 | $1,054,000 | 0.25% |
| Orbimed Advisors | 340,480 | $16,517,000 | 0.21% |
| Parkman Healthcare Partners LLC | 12,500 | $606,000 | 0.16% |
| Sepio Capital, LP | 18,400 | $893,000 | 0.10% |
| FRED ALGER MANAGEMENT, LLC | 465,832 | $22,598,000 | 0.07% |